Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Hayder M. Al-kuraishy, Majid S. Jabir, Ali I. Al-Gareeb, Hebatallah M. Saad, Gaber El-Saber Batiha & Daniel J. Klionsky. (2023) The beneficial role of autophagy in multiple sclerosis: Yes or No?. Autophagy 0:0, pages 1-16.
Read now
Read now
Niloufar Rahiman, Parvin Zamani, Ali Badiee, Leila Arabi, Seyedeh Hoda Alavizadeh & Mahmoud Reza Jaafari. (2021) An insight into the role of liposomal therapeutics in the reversion of multiple sclerosis. Expert Opinion on Drug Delivery 18:12, pages 1795-1813.
Read now
Read now
Kévin Bigaut, Jérôme De Seze & Nicolas Collongues. (2019) Ocrelizumab for the treatment of multiple sclerosis. Expert Review of Neurotherapeutics 19:2, pages 97-108.
Read now
Read now
Articles from other publishers (59)
Ameer A. Alameri, Muhammad Usman Ghanni, Arsalan AliMandeep Singh, Moaed E. Al-Gazally, Abbas F. Almulla, Andrés Alexis Ramírez-Coronel, Yasser Fakri Mustafa, Reena Gupta, Rasha Fadhel Obaid, Gamal A. Gabr & Bagher Farhood. (2023) The Effects of Curcumin on Astrocytes in Common Neurodegenerative
Conditions. Mini-Reviews in Medicinal Chemistry 23:22, pages 2117-2129.
Crossref
Crossref
Steven C. Pike, Francesca Gilli & Andrew R. Pachner. (2023) The CXCL13 Index as a Predictive Biomarker for Activity in Clinically Isolated Syndrome. International Journal of Molecular Sciences 24:13, pages 11050.
Crossref
Crossref
Susanne Bejerot, Sofia Sigra Stein, Elisabet Welin, Daniel Eklund, Ulrika Hylén & Mats B. Humble. (2023) Rituximab as an adjunctive treatment for schizophrenia spectrum disorder or obsessive-compulsive disorder: Two open-label pilot studies on treatment-resistant patients. Journal of Psychiatric Research 158, pages 319-329.
Crossref
Crossref
Weixi Feng, Yanli Zhang, Shixin Ding, Sijia Chen, Tianqi Wang, Ze Wang, Ying Zou, Chengyu Sheng, Yan Chen, Yingting Pang, Charles Marshall, Jingping Shi, Maiken Nedergaard, Qian Li & Ming Xiao. (2023) B lymphocytes ameliorate Alzheimer’s disease-like neuropathology via interleukin-35. Brain, Behavior, and Immunity 108, pages 16-31.
Crossref
Crossref
Juan Luis Chico-García, Fernando Rodríguez-Jorge, Raquel Sainz-Amo, Enric Monreal, Paulette Walo-Delgado, Ernesto Roldán, Eulalia Rodríguez-Martín, Jaime Masjuan, Lucienne Costa-Frossard, Susana Sainz de la Maza & Luisa Maria Villar. (2022) B-lymphocyte-guided retreatment contributes to establish good effectiveness and safety profile in MS patients treated with rituximab. Multiple Sclerosis and Related Disorders 68, pages 104218.
Crossref
Crossref
Laura Bierhansl, Hans-Peter Hartung, Orhan Aktas, Tobias Ruck, Michael Roden & Sven G. Meuth. (2022) Thinking outside the box: non-canonical targets in multiple sclerosis. Nature Reviews Drug Discovery 21:8, pages 578-600.
Crossref
Crossref
Federico Carlini, Federico Ivaldi, Francesca Gualandi, Ursula Boschert, Diego Centonze, Giuseppe Matarese, Marco Salvetti, Nicole Kerlero de Rosbo & Antonio Uccelli. (2021) Different Susceptibility of T and B Cells to Cladribine Depends On Their Levels of Deoxycytidine Kinase Activity Linked to Activation Status. Journal of Neuroimmune Pharmacology 17:1-2, pages 195-205.
Crossref
Crossref
George Crișan, Nastasia Sanda Moldovean-Cioroianu, Diana-Gabriela Timaru, Gabriel Andrieș, Călin Căinap & Vasile Chiș. (2022) Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade. International Journal of Molecular Sciences 23:9, pages 5023.
Crossref
Crossref
David J. Donnelly, Sean Preshlock, Tanpreet Kaur, Tritin Tran, Thomas C. Wilson, Karim Mhanna, Bradford D. Henderson, Daniel Batalla, Peter J. H. Scott & Xia Shao. (2022) Synthesis of Radiopharmaceuticals via “In-Loop” 11C-Carbonylation as Exemplified by the Radiolabeling of Inhibitors of Bruton's Tyrosine Kinase. Frontiers in Nuclear Medicine 1.
Crossref
Crossref
Fereshteh Ashtari, Reyhanehsadat Madanian, SayyedHamid Zarkesh & Arshia Ghalamkari. (2022) Serum levels of interleukin-6 and Vitamin D at the onset of multiple sclerosis and neuromyelitis optica: A pilot study. Journal of Research in Medical Sciences 27:1, pages 67.
Crossref
Crossref
M. V. Melnikov, M. V. Pashenkov & A. N. Boyko. (2022) Perspectives for Dopaminergic Therapy in Multiple Sclerosis. Neuroscience and Behavioral Physiology 52:1, pages 15-17.
Crossref
Crossref
Clara Grazia Chisari, Eleonora Sgarlata, Sebastiano Arena, Simona Toscano, Maria Luca & Francesco Patti. (2021) Rituximab for the treatment of multiple sclerosis: a review. Journal of Neurology 269:1, pages 159-183.
Crossref
Crossref
Louisa Nitsch, Simon Petzinna, Julian Zimmermann, Linda Schneider, Marius Krauthausen, Michael T. Heneka, Daniel R. Getts, Albert Becker & Marcus Müller. (2021) Astrocyte-specific expression of interleukin 23 leads to an aggravated phenotype and enhanced inflammatory response with B cell accumulation in the EAE model. Journal of Neuroinflammation 18:1.
Crossref
Crossref
Justine Perez, Fabienne Reymond, Étienne Brudieu, Pierrick Bedouch & Benoît Allenet. (2021) Place de l’ocrelizumab dans la prise en charge de la sclérose en plaque : enjeux pour le pharmacien hospitalier. Le Pharmacien Hospitalier et Clinicien 56:4, pages 355-360.
Crossref
Crossref
Riccardo Nistri, Elena Barbuti, Virginia Rinaldi, Laura Tufano, Valeria Pozzilli, Antonio Ianniello, Fabiana Marinelli, Giovanna De Luca, Luca Prosperini, Valentina Tomassini & Carlo Pozzilli. (2021) Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases. Frontiers in Neurology 12.
Crossref
Crossref
Erin M. Rice, Smathorn Thakolwiboon & Mirla Avila. (2021) Geographic heterogeneity in the association of varicella-zoster virus seropositivity and multiple sclerosis: A systematic review and meta-analysis. Multiple Sclerosis and Related Disorders 53, pages 103024.
Crossref
Crossref
Maria Podbielska, Joan O’Keeffe & Anna Pokryszko-Dragan. (2021) New Insights into Multiple Sclerosis Mechanisms: Lipids on the Track to Control Inflammation and Neurodegeneration. International Journal of Molecular Sciences 22:14, pages 7319.
Crossref
Crossref
Recai Turkoglu, Vuslat Yilmaz, Ozkan Ozdemir, Ece Akbayir, Gulcin Benbir, Erdil Arsoy, Melis Sen, Canan Ulusoy, Selen Ozyurt, Nesrin Balic, Elif Sanli, Cem Ismail Kucukali, Derya Karadeniz & Erdem Tuzun. (2021) Peripheral blood B cell subset ratios and expression levels of B cell-associated genes are altered in benign multiple sclerosis. Multiple Sclerosis and Related Disorders 52, pages 103019.
Crossref
Crossref
Xavier Dagenais-Lussier, Hamza Loucif, Cherifa Beji, Roman Telittchenko, Jean-Pierre Routy & Julien van Grevenynghe. (2021) Latest developments in tryptophan metabolism: Understanding its role in B cell immunity. Cytokine & Growth Factor Reviews 59, pages 111-117.
Crossref
Crossref
Agata Matejuk, Arthur A. Vandenbark & Halina Offner. (2021) Cross-Talk of the CNS With Immune Cells and Functions in Health and Disease. Frontiers in Neurology 12.
Crossref
Crossref
Moncef Zouali. (2021) B lymphocytes, the gastrointestinal tract and autoimmunity. Autoimmunity Reviews 20:4, pages 102777.
Crossref
Crossref
Valeria Donisi, Alberto Gajofatto, Maria Angela Mazzi, Francesca Gobbin, Isolde Martina Busch, Annamaria Ghellere & Michela Rimondini. (2021) Insights for Fostering Resilience in Young Adults With Multiple Sclerosis in the Aftermath of the COVID-19 Emergency: An Italian Survey. Frontiers in Psychiatry 11.
Crossref
Crossref
M.V. Melnikov, M.V. Pashenkov & A.N. Boyko. (2021) The prospect of dopaminergic therapy in multiple sclerosis. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 121:2, pages 67.
Crossref
Crossref
Hadi Atabati, Esmaeil Yazdanpanah, Hamed Mortazavi, Saeed Gharibian bajestani, Amir Raoofi, Seyed-Alireza Esmaeili, Azad Khaledi, Ehsan Saburi, Jalil Tavakol Afshari, Thozhukat Sathyapalan, Abbas Shapouri Moghaddam & Amirhossein Sahebkar. 2021. Reviews on New Drug Targets in Age-Related Disorders. Reviews on New Drug Targets in Age-Related Disorders
87
105
.
Vinzenz Fleischer. 2021. Translational Methods for Multiple Sclerosis Research. Translational Methods for Multiple Sclerosis Research
287
301
.
Nathalia Bernardes Teixeira, Gisele Picolo, Aline Carolina Giardini, Fawzi Boumezbeur, Géraldine Pottier, Bertrand Kuhnast, Denis Servent & Evelyne Benoit. (2020) Alterations of peripheral nerve excitability in an experimental autoimmune encephalomyelitis mouse model for multiple sclerosis. Journal of Neuroinflammation 17:1.
Crossref
Crossref
Louise Cummings. 2020. Language in Dementia. Language in Dementia.
Rina Aharoni, Raya Eilam, Nofar Schottlender, Lihi Radomir, Sandra Leistner-Segal, Tali Feferman, Dana Hirsch, Michael Sela & Ruth Arnon. (2020) Glatiramer acetate increases T- and B -regulatory cells and decreases granulocyte-macrophage colony-stimulating factor (GM-CSF) in an animal model of multiple sclerosis. Journal of Neuroimmunology 345, pages 577281.
Crossref
Crossref
Jonas Graf, Philipp Albrecht, Norbert Goebels, Orhan Aktas & Hans-Peter Hartung. (2020) Ocrelizumab zur Behandlung der Multiplen SkleroseOcrelizumab for treatment of multiple sclerosis. Der Nervenarzt 91:8, pages 722-734.
Crossref
Crossref
Zehui Liu, Qian Hu, Wanyan Wang, Sisi Lu, Dang Wu, Shuyin Ze, Jiacheng He, Ying Huang, Wuyan Chen, Yechun Xu, Weiqiang Lu & Jin Huang. (2020) Natural product piperine alleviates experimental allergic encephalomyelitis in mice by targeting dihydroorotate dehydrogenase. Biochemical Pharmacology 177, pages 114000.
Crossref
Crossref
Asaf Achiron, Idan Hecht, Lena Abayev, Liron Naftali Ben Haim, Anna Feldman & Michael Gurevich. (2019) B-cell related biomarkers associated with severity of the first demyelinating event of acute optic neuritis. Eye 34:5, pages 954-959.
Crossref
Crossref
Rune A. Høglund, Robert D. Bremel, E. Jane Homan, Silje Bøen Torsetnes, Andreas Lossius & Trygve Holmøy. (2020) CD4+ T Cells in the Blood of MS Patients Respond to Predicted Epitopes From B cell Receptors Found in Spinal Fluid. Frontiers in Immunology 11.
Crossref
Crossref
D. Pandya, V. Hellerslia & E. Gettings. (2020) Acquired factor VIII inhibitor in a patient with multiple sclerosis treated with interferon β-1a. Journal of Neuroimmunology 340, pages 577146.
Crossref
Crossref
K. Bigaut & N. Collongues. (2020) Intérêt du rituximab dans les SEP progressives. Pratique Neurologique - FMC 11:1, pages 1-9.
Crossref
Crossref
Manolo Sambucci, Francesca Gargano, Gisella Guerrera, Luca Battistini & Giovanna Borsellino. (2019) One, No One, and One Hundred Thousand: T Regulatory Cells' Multiple Identities in Neuroimmunity. Frontiers in Immunology 10.
Crossref
Crossref
Krista D. DiSano, Michael R. Linzey, Darlene B. Royce, Andrew R. Pachner & Francesca Gilli. (2019) Differential neuro-immune patterns in two clinically relevant murine models of multiple sclerosis. Journal of Neuroinflammation 16:1.
Crossref
Crossref
Anders Fugl & Christen Lykkegaard Andersen. (2019) Epstein-Barr virus and its association with disease - a review of relevance to general practice. BMC Family Practice 20:1.
Crossref
Crossref
Ben Korin, Shimrit Avraham, Hilla Azulay-Debby, Dorit Farfara, Fahed Hakim & Asya Rolls. (2019) Short-term sleep deprivation in mice induces B cell migration to the brain compartment. Sleep.
Crossref
Crossref
Paulus S. Rommer, Ron Milo, May H. Han, Sammita Satyanarayan, Johann Sellner, Larissa Hauer, Zsolt Illes, Clemens Warnke, Sarah Laurent, Martin S. Weber, Yinan Zhang & Olaf Stuve. (2019) Immunological Aspects of Approved MS Therapeutics. Frontiers in Immunology 10.
Crossref
Crossref
Bardia Nourbakhsh & Ellen M. Mowry. (2019) Multiple Sclerosis Risk Factors and Pathogenesis. CONTINUUM: Lifelong Learning in Neurology 25:3, pages 596-610.
Crossref
Crossref
Marco Puthenparampil, Antonio Zito, Giorgia Pantano, Lisa Federle, Erica Stropparo, Silvia Miante, Giustina De Silvestro, Mario Plebani & Paolo Gallo. (2018) Peripheral imbalanced TFH/TFR ratio correlates with intrathecal IgG synthesis in multiple sclerosis at clinical onset. Multiple Sclerosis Journal 25:7, pages 918-926.
Crossref
Crossref
Michael Dietrich, Orhan Aktas, Hans-Peter Hartung & Philipp Albrecht. (2019) Assessing the anterior visual pathway in optic neuritis: recent experimental and clinical aspects. Current Opinion in Neurology 32:3, pages 346-357.
Crossref
Crossref
Navina L Chrobok, John G J M Bol, Micha M M Wilhelmus, Benjamin Drukarch & Anne-Marie van Dam. (2019) Tissue Transglutaminase Appears in Monocytes and Macrophages but Not in Lymphocytes in White Matter Multiple Sclerosis Lesions. Journal of Neuropathology & Experimental Neurology 78:6, pages 492-500.
Crossref
Crossref
Munibah Qureshi, Ebtesam Al-Suhaimi & Adeeb Shehzad. 2019. Curcumin for Neurological and Psychiatric Disorders. Curcumin for Neurological and Psychiatric Disorders
365
380
.
Gisa Ellrichmann, Jan Bolz, Maren Peschke, Alexander Duscha, Kerstin Hellwig, De-Hyung Lee, Ralf A. Linker, Ralf Gold & Aiden Haghikia. (2018) Peripheral CD19+ B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders. Journal of Neurology 266:1, pages 57-67.
Crossref
Crossref
Vanessa Beynon, Radhika Raheja, Maria Mazzola & Howard Weiner. 2019. Neurorheumatology. Neurorheumatology
3
9
.
Caterina Veroni, Barbara Serafini, Barbara Rosicarelli, Corrado Fagnani & Francesca Aloisi. (2018) Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis. Journal of Neuroinflammation 15:1.
Crossref
Crossref
Richard M. Ransohoff. (2018) Immune-cell crosstalk in multiple sclerosis. Nature 563:7730, pages 194-195.
Crossref
Crossref
Nikita A. Mitkin, Alisa M. Muratova, Kirill V. Korneev, Vsevolod V. Pavshintsev, Konstantin A. Rumyantsev, Murad S. Vagida, Aksinya N. Uvarova, Marina A. Afanasyeva, Anton M. Schwartz & Dmitry V. Kuprash. (2018) Protective C allele of the single-nucleotide polymorphism rs1335532 is associated with strong binding of Ascl2 transcription factor and elevated CD58 expression in B-cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1864:10, pages 3211-3220.
Crossref
Crossref
Florent Arbogast & Frédéric Gros. (2018) Lymphocyte Autophagy in Homeostasis, Activation, and Inflammatory Diseases. Frontiers in Immunology 9.
Crossref
Crossref
S. G. Meuth, T. Ruck, O. Aktas & H.-P. Hartung. (2018) Cladribin-TablettenCladribine tablets. Der Nervenarzt 89:8, pages 895-907.
Crossref
Crossref
Zhaolan Hu, Yanhui Cui, Xiaoqing Qiao, Xinwen He, Fang Li, Cong Luo, Shuang Wang, Changqi Li & Ruping Dai. (2018) Silencing miR-150 Ameliorates Experimental Autoimmune Encephalomyelitis. Frontiers in Neuroscience 12.
Crossref
Crossref
Şerife Deniz Aktura, Vuslat Yılmaz, Duygu Özkan-Yaşargün, Canan Ulusoy, Erdem Tüzün & Recai Türkoğlu. (2018) Peripheral blood memory B cell frequency predicts conversion from clinically isolated syndrome to multiple sclerosis. Multiple Sclerosis and Related Disorders 23, pages 9-14.
Crossref
Crossref
Munibah Qureshi, Ebtesam A. Al-Suhaimi, Fazli Wahid, Omer Shehzad & Adeeb Shehzad. (2017) Therapeutic potential of curcumin for multiple sclerosis. Neurological Sciences 39:2, pages 207-214.
Crossref
Crossref
Jan Krejsek. (2017) Biological therapy by Ocrelizumab (antiCD20) is surprisingly clinically effective in multiple sclerosis patients. Neurologie pro praxi 18:6, pages 403-407.
Crossref
Crossref
Anna-Kaisa Försti, Laura Huilaja, Enno Schmidt & Kaisa Tasanen. (2017) Neurological and psychiatric associations in bullous pemphigoid-more than skin deep?. Experimental Dermatology 26:12, pages 1228-1234.
Crossref
Crossref
David C. Wraith. (2017) The Future of Immunotherapy: A 20-Year Perspective. Frontiers in Immunology 8.
Crossref
Crossref
Zuzana Matejčíková & Jan Mareš. (2017) T- lymphocytes and B-lymphocytes ant their role in multiple sclerosis. Neurologie pro praxi 18:5, pages 318-321.
Crossref
Crossref
Narges Dargahi, Maria Katsara, Theodore Tselios, Maria-Eleni Androutsou, Maximilian de Courten, John Matsoukas & Vasso Apostolopoulos. (2017) Multiple Sclerosis: Immunopathology and Treatment Update. Brain Sciences 7:12, pages 78.
Crossref
Crossref